STOCK TITAN
  1. Home
  2. Sec-filings
  3. ORIC
  4. [SCHEDULE 13G/A] Oric Pharmaceuticals, Inc. SEC Filing

[SCHEDULE 13G/A] Oric Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ORIC logo
Oric Pharmaceuticals, Inc.

NASDAQ:ORIC

ORIC Rankings

#2450 Ranked by Market Cap
N/A Ranked by Dividends

ORIC Latest News

Sep 5, 2025
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Aug 27, 2025
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 18, 2025
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
Aug 12, 2025
ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates
Aug 1, 2025
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

ORIC Latest SEC Filings

Oct 8, 2025
[Form 4] Oric Pharmaceuticals, Inc. Insider Trading Activity
Oct 8, 2025
[Form 4] Oric Pharmaceuticals, Inc. Insider Trading Activity
Oct 6, 2025
[144] Oric Pharmaceuticals, Inc. SEC Filing
Sep 24, 2025
[Form 4] Oric Pharmaceuticals, Inc. Insider Trading Activity
Sep 24, 2025
[Form 4] Oric Pharmaceuticals, Inc. Insider Trading Activity

ORIC Stock Data

1.37B
88.57M
6.94%
99.21%
8.42%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO